Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

NCT05387031 · clinicaltrials.gov ↗

RECRUITING

Status

239

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease
Stricture; Bowel
Intestinal Stricture

Interventions

DRUG: Ustekinumab

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]